🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04581122
Recruiting Not applicable

A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components

NCT04581122 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Started
2020-09-01
Last updated
2020-10-09

Condition(s) studied

Progression

Investigational drug(s) / intervention(s)

Lymphadenectomy

Lymphadenectomy: Patients with ground glass nodules smaller than 3cm and with more than 50%solid components would randomly assigned to selective lymphadenectomy group or systematic lymph node dissection group

Study summary

A multiple-center study on the effect of different ways of lymph node dissection on the prognosis of less than 3cm ground glass nodules with more than solid components

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Aged between 18 and 75 years; 2. GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT); 3. The maximum diameter of the GGO is smaller than 3cm; 4. The maximum diameter of the solid component in the GGO is more than 50%; 5. The patient is able to undergo the lobectomy 6. The patient is able to understand and comply with the study and has provided written informed consent. Exclusion Criteria: \- Patients meeting any of the following criteria are not eligible for this trial: 1. Patients with a history of using immunosuppressive or hormonal drugs; 2. Patients receiving radiotherapy or chemotherapy; 3. Patients who fail to comply with our follow-up strategy; 4. Other situations that are not in conformity with the standards and requirements of this trial.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jiang Wei Shanghai China Recruiting

More Shanghai Zhongshan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04581122 on ClinicalTrials.gov ↗ ← All trials in China